SYGGF - Synairgen - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

11.56M

Cash

19.68M

Avg Qtr Burn

-3.572M

Short % of Float

0.00%

Insider Ownership

3.35%

Institutional Own.

30.17%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SG016 / SNG001 Details COVID-19	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFN-β (SNG001) Details Chronic Obstructive Pulmonary Disease (COPD)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.